| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 443 |
| 1 | IBRUTINIB | 406 |
| 2 | LENALIDOMIDE | 267 |
| 3 | BORTEZOMIB | 213 |
| 4 | VENETOCLAX | 206 |
| 5 | CYCLOPHOSPHAMIDE | 174 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 174 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 174 |
| 8 | PREDNISONE | 155 |
| 9 | CYTARABINE | 143 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIRTOBRUTINIB | 19 | 0.0194 |
| 1 | BREXUCABTAGENE AUTOLEUCEL | 37 | 0.0171 |
| 2 | GLOFITAMAB | 33 | 0.0122 |
| 3 | RITUXIMAB-ABBS | 40 | 0.0078 |
| 4 | BENDAMUSTINE HCL | 103 | 0.0066 |
| 5 | CARMUSTINE | 30 | 0.0064 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 51 | 0.0060 |
| 7 | IBRITUMOMAB TIUXETAN | 9 | 0.0059 |
| 8 | ZANUBRUTINIB | 23 | 0.0051 |
| 9 | IBRUTINIB | 406 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 502 |
| 1 | Kinase Inhibitor [EPC] | 476 |
| 2 | Corticosteroid [EPC] | 284 |
| 3 | Thalidomide Analog [EPC] | 269 |
| 4 | Proteasome Inhibitor [EPC] | 214 |
| 5 | BCL-2 Inhibitor [EPC] | 206 |
| 6 | Alkylating Drug [EPC] | 186 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 150 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 33 | 0.0082 |
| 1 | BCL-2 Inhibitor [EPC] | 206 | 0.0033 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | Proteasome Inhibitor [EPC] | 214 | 0.0019 |
| 4 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 502 | 0.0016 |
| 6 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 7 | Interferon gamma [EPC] | 2 | 0.0014 |
| 8 | Kinase Inhibitor [EPC] | 476 | 0.0009 |
| 9 | Alkylating Drug [EPC] | 186 | 0.0008 |